GSK's Curbs On Parallel Trading May Be Illegal: Court

Law360, New York (September 16, 2008, 12:00 AM EDT) -- A GlaxoSmithKline PLC subsidiary's practice of selling three drugs in Greece on a quota system in order to combat parallel trading may constitute a violation of competition laws, Europe's highest court said Tuesday.

The ruling by the European Court of Justice, which holds that a pharmaceutical company is abusing its dominant position if it refuses to meet “ordinary” orders by wholesalers in order to prevent parallel exports, comes in a long-running court battle Glaxo subsidiary GlaxoSmithKline AEVE has been facing over the practice.

Whether Glaxo's orders...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.